ResMed, Inc.

ISIN AU000000RMD6

 | 

WKN 935168

Market cap (in EUR)
30,321 m
Country
United States
Sector
Healthcare
Dividend yield
0.95%
Advertisement
Capital at risk. Execution-only service.
 

Overview

Description

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
Show more Show less
Healthcare Healthcare Equipment Other Medical Devices United States

Financials

Key metrics

Market capitalisation, EUR 30,321 m
EPS, EUR 0.89
P/B ratio 5.8
P/E ratio 24.4
Dividend yield 0.95%

Income statement (2025)

Revenue, EUR 4,736 m
Net income, EUR 1,289 m
Profit margin 27.22%
Advertisement
JPMorgan
Fixed income works harder with active ETFs
The home of active ETFs
Explore
Capital at risk

What ETF is ResMed, Inc. in?

There is 1 ETF which contains ResMed, Inc..
ETF Weight Investment focus Fund size (in m EUR)
Xtrackers S&P/ASX 200 UCITS ETF 1D 0.88%
Equity
Australia
61
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.